Maxim Group Starts SciClone Pharmaceuticals (SCLN) at Buy
Tweet Send to a Friend
Maxim Group initiates coverage on SciClone Pharmaceuticals (NASDAQ: SCLN) with a Buy rating and a price target of $14.00.Analyst Gabrielle ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
